METHOD FOR DETERMINATION OF TARGET CELLS OR TISSUE FOR EXTRACTION OF BIOMOLECULES FROM FIXED BIOLOGICAL SAMPLES

• US 20130095473A1
• Filed: 06/14/2011
• Published: 04/18/2013
• Est. Priority Date: 06/14/2010
• Status: Active Application

• Current Assignee: Qiagen GmbH (Qiagen NV)
• Original Assignee: Qiagen GmbH (Qiagen NV)
• Inventors: Groelz, Daniel
• Application Number:
  US13/703,309
• Publication Number:
  US 20130095473A1
• Time in Patent Office: Days
• US Class Current: 435/6.1
• CPC Class Codes: C12N 15/1003 Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
• CPC Class Codes: C12Q 1/6806 Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay C12Q1/6804 takes precedence

Abstract

The present invention relates to a method for determination of target cells or tissue for isolating or extracting biomolecules from fixed biological samples, the preparation of a sample in a method for extracting, isolating and/or purifying biomolecules from a fixed biological sample as well as to a kit for visualizing target cells or tissue in a fixed biological sample for extracting, isolating and/or purifying biomolecules from said target cells or tissue.

Claims

1-14. -14. (canceled)

15. A method for determining target cells or tissue for isolation, extraction or purification of biomolecules from a fixed biological sample, comprising:

(1) mounting at least one part of the fixed biological sample on at least one support,

(2) optionally treating the at least one part of the sample with a sample treatment agent, wherein said treatment can be carried out at any stage of the procedure before step (6),

(3) staining the at least one part of the fixed biological sample mounted on the at least one support,

(4) considering the at least one part stained in step (3) to determine target cells or tissue comprising biomolecules of interest,

(5) separating target cells or tissue comprising biomolecules of interest from the remainder of the fixed sample mounted on the at least one support, and

(6) isolating the biomolecules from the separated target cells or tissue.

16. The method according to claim 15, wherein the biomolecules comprise RNA.

24. The method according to claim 15, wherein the at least one support is transparent.

25. The method according to claim 24, wherein the at least one support is made of glass or a transparent polymer.

26. The method according to claim 15, wherein the sample in step (4) is considered under light or backlight.

27. The method according to claim 26, wherein the sample in step (4) is considered under a microscope.

28. The method according to claim 15, wherein the target cells or tissue is/are separated in step (5) by microdissection, laser capture microdissection, scraping, or cutting out.

37. A method according to claim 15, wherein a fixed biological sample is divided in sections of 0.5 to 12 μ

m thickness, and

in step (1), at least two of said sections which were in the original sample adjacent to each other are mounted on separate transparent supports each,

optionally at any stage of the procedure independently from each other, the sections are treated with a de-waxing agent according to step (2) if a wax-embedded sample was used,

in step (3), at least one of the sections is stained with at least one tissue staining agent and an adjacent section is not stained,

in step (4), cells or tissue of interest is/are determined and marked in the stained sample section and the transparent support with the unstained sample section is stacked on top of the stained and marked sample section in the same orientation as in the original sample,

in step (5), the cells or tissue of the unstained sample on top of the marked area of the stained sample is/are separated from the remainder of the unstained sample, the remainder is waived, and the cells/tissue corresponding to the marked area of the stained sample is retained, and

in step (6), nucleic acids are isolated or extracted from the cells retained in step (5).

38. The method according to claim 15, wherein a fixed biological sample is divided in sections of 0.5 to 12 μ

m thickness, and

in step (1), at least one of said sections is mounted on a transparent support,

in step (2), the section is treated with a de-waxing agent if a wax-embedded sample was used,

in step (3), said section is stained with for not more than 60 seconds with a first tissue staining agent, raised with water, and thereafter optionally stained for less than 10 seconds with a second tissue staining agent,

in step (4), cells or tissue of interest is/are determined in the stained sample section,

in step (5), the cells or tissue of interest is/are separated from the remainder of the stained sample, the remainder is waived, and

in step (6), nucleic acids are isolated or extracted from the cells obtained in step (5).

29. A method for staining a fixed biological sample, comprising:

(a) contacting a fixed biological sample for not more than 60 seconds with a first tissue staining agent,

(b) rinsing the sample with water, and

(c) thereafter optionally contacting the sample for less than 10 seconds with a second tissue staining agent.

30. The method according to claim 29, wherein the sample is a wax-embedded non-formalin-fixed paraffin-embedded sample (non-FFPE-sample).

31. The method according to claim 29, wherein the sample comprises at least one section of 0.5 to 12 μ

m thickness of a non-formalin-fixed paraffin-embedded sample.

32. The method according to claim 29, wherein step (a) comprises contacting the sample for less than 45 seconds with the first tissue staining agent.

33. The method according to claim 32, wherein step (a) comprises contacting the sample for less than 30 seconds with the first tissue staining agent.

34. The method according to claim 33, wherein step (a) comprises contacting the sample for less than 15 seconds with the first tissue staining agent.

35. The method according to claim 29, wherein the sample is contacted for up to 30 seconds with Hematoxylin and less than 3 seconds with Eosin.

36. The method according to claim 35, wherein the sample is contacted for less than 1 second with Eosin.

39. The method according to claim 29, further comprising isolating biomolecules from the sample or a part thereof that has been stained with the first tissue staining agent and optionally the second tissue staining agent.

40. The method according to claim 39, wherein the biomolecules comprise RNA.

41. A kit for visualizing biomolecules comprising target cells or tissue in a fixed biological sample during a method for extracting, isolating and/or purifying biomolecules from said target cells or tissue, comprising:

(i) optionally at least one transparent support,

(iii) optionally at least one sample treatment agent,

(iv) instructions for a method according to claim 29, and

(v) at least one buffer and/or equipment for isolating biomolecules, preferably nucleic acids, most preferably comprising RNA.

42. A kit for extracting, isolating and/or purifying biomolecules from a biological sample, comprising:

(i) optionally instructions for fixing the biological sample,

(ii) optionally a fixing agent or mixture not comprising formalin,

(iii) optionally at least one transparent support,

(iv) optionally at least one tissue staining agent,

(v) optionally at least one sample treatment agent,

(vi) instructions for a method according to claim 29, (vii) at least one buffer and/or equipment for isolating biomolecules, preferably nucleic acids, most preferably comprising RNA.